Massachusetts
State Director
Sue Dubman
Tewksbury, MA
sdubman@gmail.com
978-455-1314
Parkinson’s Disease-Related Federal Funding in Massachusetts
National Institutes of Health (NIH)
Non American Recovery and Reinvestment Act (Non-ARRA)
• Brigham and Women’s Hospital
• Beth Israel Deaconess Medical Center
• Boston University Medical Campus
• University of Massachusetts Medical School Worchester
• Massachusetts General Hospital
• Boston University
• Harvard University (School of Public Health)
• Whitehead Institute for Biomedical Research
• Brandeis University
• Physical Sciences, INC
• Ekam Imaging, INC
• Mc Lean Hospital (Belmont, MA)
• Children’s Hospital Boston
Total Non-ARRA funding $11,361,550
Actual ARRA
• Mc Lean Hospital (Belmont, MA)
• Massachusettes General Hospital
Total ARRA funding $2,380,655
Department of Veterans Affairs Parkinson’s Disease Research, Education and Clinical Centers (PADRECC) and Consortium Sites
• VA Boston Healthcare System, Jamaica Plain Campus in Jamaica Plain, MA
Department of Defense (DoD)
Neurotoxin Exposure Treatment Parkinson's Research (NETPR) program grantees:
• Protection by Purines in Toxin Models of Parkinson's Disease in Boston, MA
• Regenerative Cell Therapy for Parkinson's Disease and Neurodegenerative Conditions in Belmont, MA
Latest From PAN
Representative Levin (MI-12) has signed on to HR 2595! Contact your Representative today!
Read PAN's January 2012 Monthly Message!
NIH highlights the launch of the new National Center for Advancing Translational Science. Read more.
Join Us - Take Action
Let your voice be heard. Become a part of our Parkinson’s advocacy network. Privacy Policy.




